HALO – halozyme therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Mahesh Krishnan Elected to Halozyme's Board of Directors [Yahoo! Finance]
Mahesh Krishnan Elected to Halozyme's Board of Directors
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
Halozyme to Report First Quarter 2024 Financial and Operating Results [Yahoo! Finance]
Form 4 HALOZYME THERAPEUTICS, For: Apr 25 Filed by: Posard Matthew L.
Form 4 HALOZYME THERAPEUTICS, For: Apr 25 Filed by: Miyashita Akiko Moni
Form 4 HALOZYME THERAPEUTICS, For: Apr 25 Filed by: MATSUI CONNIE
Form 4 HALOZYME THERAPEUTICS, For: Apr 25 Filed by: Krishnan Mahesh
Form 4 HALOZYME THERAPEUTICS, For: Apr 25 Filed by: Henderson Jeffrey William
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.